238 related articles for article (PubMed ID: 34503062)
1. Thyroid Hormone Receptor Beta as Tumor Suppressor: Untapped Potential in Treatment and Diagnostics in Solid Tumors.
Davidson CD; Gillis NE; Carr FE
Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503062
[TBL] [Abstract][Full Text] [Related]
2. Thyroid Hormone Receptor Beta Induces a Tumor-Suppressive Program in Anaplastic Thyroid Cancer.
Bolf EL; Gillis NE; Davidson CD; Rodriguez PD; Cozzens L; Tomczak JA; Frietze S; Carr FE
Mol Cancer Res; 2020 Oct; 18(10):1443-1452. PubMed ID: 32554601
[TBL] [Abstract][Full Text] [Related]
3. The Thyroid Hormone Receptor-RUNX2 Axis: A Novel Tumor Suppressive Pathway in Breast Cancer.
Bolf EL; Gillis NE; Barnum MS; Beaudet CM; Yu GY; Tomczak JA; Stein JL; Lian JB; Stein GS; Carr FE
Horm Cancer; 2020 Feb; 11(1):34-41. PubMed ID: 31865591
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional activation by thyroid hormone receptor-beta involves chromatin remodeling, histone acetylation, and synergistic stimulation by p300 and steroid receptor coactivators.
Lee KC; Li J; Cole PA; Wong J; Kraus WL
Mol Endocrinol; 2003 May; 17(5):908-22. PubMed ID: 12586842
[TBL] [Abstract][Full Text] [Related]
5. TRβ Agonism Induces Tumor Suppression and Enhances Drug Efficacy in Anaplastic Thyroid Cancer in Female Mice.
Gillis NE; Cozzens LM; Wilson ER; Smith NM; Tomczak JA; Bolf EL; Carr FE
Endocrinology; 2023 Aug; 164(10):. PubMed ID: 37702560
[TBL] [Abstract][Full Text] [Related]
6. Thyroid Hormone Receptor-β (TRβ) Mediates Runt-Related Transcription Factor 2 (Runx2) Expression in Thyroid Cancer Cells: A Novel Signaling Pathway in Thyroid Cancer.
Carr FE; Tai PW; Barnum MS; Gillis NE; Evans KG; Taber TH; White JH; Tomczak JA; Jaworski DM; Zaidi SK; Lian JB; Stein JL; Stein GS
Endocrinology; 2016 Aug; 157(8):3278-92. PubMed ID: 27253998
[TBL] [Abstract][Full Text] [Related]
7. Thyroid Hormone Receptor β Suppression of RUNX2 Is Mediated by Brahma-Related Gene 1-Dependent Chromatin Remodeling.
Gillis NE; Taber TH; Bolf EL; Beaudet CM; Tomczak JA; White JH; Stein JL; Stein GS; Lian JB; Frietze S; Carr FE
Endocrinology; 2018 Jun; 159(6):2484-2494. PubMed ID: 29750276
[TBL] [Abstract][Full Text] [Related]
8. Regulation of cancer stem cell activity by thyroid hormone receptor β.
Lee WK; Zhu X; Park S; Zhu YJ; Zhao L; Meltzer P; Cheng SY
Oncogene; 2022 Apr; 41(16):2315-2325. PubMed ID: 35256781
[TBL] [Abstract][Full Text] [Related]
9. Loss of tyrosine phosphorylation at Y406 abrogates the tumor suppressor functions of the thyroid hormone receptor β.
Park JW; Zhao L; Willingham MC; Cheng SY
Mol Carcinog; 2017 Feb; 56(2):489-498. PubMed ID: 27254276
[TBL] [Abstract][Full Text] [Related]
10. Targeting thyroid hormone receptor beta in triple-negative breast cancer.
Gu G; Gelsomino L; Covington KR; Beyer AR; Wang J; Rechoum Y; Huffman K; Carstens R; Andò S; Fuqua SA
Breast Cancer Res Treat; 2015 Apr; 150(3):535-45. PubMed ID: 25820519
[TBL] [Abstract][Full Text] [Related]
11. Common tumor-suppressive signaling of thyroid hormone receptor beta in breast and thyroid cancer cells.
Bolf EL; Gillis NE; Davidson CD; Cozzens LM; Kogut S; Tomczak JA; Frietze S; Carr FE
Mol Carcinog; 2021 Dec; 60(12):874-885. PubMed ID: 34534367
[TBL] [Abstract][Full Text] [Related]
12. Thyroid Hormone Receptor Beta Inhibits PI3K-Akt-mTOR Signaling Axis in Anaplastic Thyroid Cancer via Genomic Mechanisms.
Davidson CD; Bolf EL; Gillis NE; Cozzens LM; Tomczak JA; Carr FE
J Endocr Soc; 2021 Aug; 5(8):bvab102. PubMed ID: 34258492
[TBL] [Abstract][Full Text] [Related]
13. Tumor suppressor action of liganded thyroid hormone receptor beta by direct repression of beta-catenin gene expression.
Guigon CJ; Kim DW; Zhu X; Zhao L; Cheng SY
Endocrinology; 2010 Nov; 151(11):5528-36. PubMed ID: 20844001
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional silencing by unliganded thyroid hormone receptor beta requires a soluble corepressor that interacts with the ligand-binding domain of the receptor.
Tong GX; Jeyakumar M; Tanen MR; Bagchi MK
Mol Cell Biol; 1996 May; 16(5):1909-20. PubMed ID: 8628257
[TBL] [Abstract][Full Text] [Related]
15. An unliganded thyroid hormone beta receptor activates the cyclin D1/cyclin-dependent kinase/retinoblastoma/E2F pathway and induces pituitary tumorigenesis.
Furumoto H; Ying H; Chandramouli GV; Zhao L; Walker RL; Meltzer PS; Willingham MC; Cheng SY
Mol Cell Biol; 2005 Jan; 25(1):124-35. PubMed ID: 15601836
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of estrogen-dependent tumorigenesis by the thyroid hormone receptor β in xenograft models.
Park JW; Zhao L; Cheng SY
Am J Cancer Res; 2013; 3(3):302-11. PubMed ID: 23841029
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of tumorigenesis by the thyroid hormone receptor β in xenograft models.
Kim WG; Zhao L; Kim DW; Willingham MC; Cheng SY
Thyroid; 2014 Feb; 24(2):260-9. PubMed ID: 23731250
[TBL] [Abstract][Full Text] [Related]
18. Ligand-dependent cross-talk between steroid and thyroid hormone receptors. Evidence for common transcriptional coactivator(s).
Zhang X; Jeyakumar M; Bagchi MK
J Biol Chem; 1996 Jun; 271(25):14825-33. PubMed ID: 8662980
[TBL] [Abstract][Full Text] [Related]
19. Thyroid hormone receptor β suppresses SV40-mediated tumorigenesis via novel nongenomic actions.
Kim DW; Zhao L; Hanover J; Willingham M; Cheng SY
Am J Cancer Res; 2012; 2(5):606-19. PubMed ID: 22957312
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the functional role of steroid receptor coactivator-1 in ligand-induced transactivation by thyroid hormone receptor.
Jeyakumar M; Tanen MR; Bagchi MK
Mol Endocrinol; 1997 Jun; 11(6):755-67. PubMed ID: 9171239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
